BRK-B vs KEY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
KeyCorp presents a stark contrast between attractive valuation and poor fundamental health. While the stock trades below its Graham Number ($24.29) and Intrinsic Value ($48.08), the Piotroski F-Score of 2/9 indicates significant weakness in financial health and operational efficiency. Strong recent earnings growth and a sustainable dividend are offset by bearish insider sentiment and a severely negative technical trend (10/100). The disconnect between analyst 'buy' ratings and the deterministic health scores suggests a value trap risk.
Compare Another Pair
Related Comparisons
BRK-B vs KEY: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and KeyCorp (KEY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.